HIV-1 Diversity, Drug-Resistant Mutations, and Viral Evolution among High-Risk Individuals in Phase II HIV Vaccine Trial Sites in Southern China

HIV-1 prevalence in Guangxi, China, has been growing since 1996, when the first case was reported. Over half of HIV-1 positive patients in Guangxi Province were injecting drug users (IDUs), possibly because of the province’s location near drug-trafficking routes. Since a phase II HIV vaccine trial i...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Haiyan, Zhao, Ke, Xu, Fei, Zhang, Xuzhao, Zhang, Zhiyong, Yang, Li, Li, Chunling, Liang, Xu, Guo, Weigui, Chen, Shihai, Liu, Zhihao, Zhang, Wenyan, Yu, Xiao-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711821/
https://www.ncbi.nlm.nih.gov/pubmed/23869225
http://dx.doi.org/10.1371/journal.pone.0068656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711821/
https://www.ncbi.nlm.nih.gov/pubmed/23869225
http://dx.doi.org/10.1371/journal.pone.0068656

Ejemplares similares